Left ventricular hypertrophy (LVH) is prognostically relevant, associated with major cardiovascular risk factors and with atherosclerosis. However, whether LVH is independently associated with impaired coronary flow reserve (CFR) and with endothelial dysfunction is disputed. We assessed the relationship of LV mass and systolic function to CFR and endothelial function in new discovered never treated subjects with essential arterial hypertension, but without coronary artery disease or microalbuminuria. LVH, ejection fraction (EF) and stress-corrected midwall shortening (MWS, a measure of myocardial contractility) were assessed by echocardiography. CFR was assessed by single-photon emission computed tomography and dipyridamole infusion. Endothelial function was evaluated by assessing 1-min postischaemic flow-mediated dilatation of the brachial artery (FMD); nitroglycerine-mediated dilatation (NMD) of the same brachial artery was used as measure of nonendothelium-dependent vasodilatation. In approximately 1 year, we enrolled 21 subjects who met stringent inclusion criteria (47710 years old, 26.672.8 kg/m 2 , 78% men). Five patients showed LVH. Multivariate analyses showed a significant negative correlation of LV mass index with FMD (b ¼ À0.61, Po0.05) but not with NMD, neither with CFR. Stress-corrected MWS showed independent correlation with CFR (b ¼ 0.51, Po0.05). Thus, in clinically healthy, new discovered hypertensive subjects, never treated and mostly in the early stage of arterial hypertension, LVH can be associated with endothelial dysfunction while maximal dipyridamoledependent CFR may be preserved; nevertheless, a cardiac phenotype presenting with tendency to impaired myocardial contractility, assessed by stress-corrected MWS, showed association with lower CFR in the early stage of arterial hypertension.
Left ventricular hypertrophy (LVH) is prognostically relevant, associated with major cardiovascular risk factors and with atherosclerosis. However, whether LVH is independently associated with impaired coronary flow reserve (CFR) and with endothelial dysfunction is disputed. We assessed the relationship of LV mass and systolic function to CFR and endothelial function in new discovered never treated subjects with essential arterial hypertension, but without coronary artery disease or microalbuminuria. LVH, ejection fraction (EF) and stress-corrected midwall shortening (MWS, a measure of myocardial contractility) were assessed by echocardiography. CFR was assessed by single-photon emission computed tomography and dipyridamole infusion. Endothelial function was evaluated by assessing 1-min postischaemic flow-mediated dilatation of the brachial artery (FMD); nitroglycerine-mediated dilatation (NMD) of the same brachial artery was used as measure of nonendothelium-dependent vasodilatation. In approximately 1 year, we enrolled 21 subjects who met stringent inclusion criteria (47710 years old, 26.672.8 kg/m Introduction Left ventricular hypertrophy (LVH) and impaired myocardial contractility are independent predictors of adverse cardiovascular outcome.
1,2 Correlation of LVH with abnormal coronary flow reserve (CFR) is one of the proposed mechanisms linking LVH to increased cardiovascular risk. LVH is often associated with proatherosclerotic risk factors, 3 which are in turn related with endothelial dysfunction. 4 An early investigation using an invasive method showed that subjects with altered peripheral endothelial function also have impaired endothelial-dependent coronary vasodilatation, 5 suggesting that abnormal endothelial function may act both as pathophysiologic mechanism in the development of atherosclerosis and determine functional abnormalities of coronary haemodynamics beyond coronary stenosis. With this regard, early experimental and clinical invasive studies reported association of LVH with reduced CFR. [6] [7] [8] [9] [10] However, others failed to find significant independent relationship between CFR and LVH, [11] [12] [13] [14] [15] [16] [17] and the independent relation between LVH and abnormal CFR remains disputed. In addition, LVH is independently associated with coronary artery disease, 18 which may confound the relation between LVH and CFR. Moreover, the relations of echocardiographically assessed myocardial contractility to CFR and endothelial function have not been previously assessed. Therefore, the aim of the present study was to investigate in parallel the relations of LV mass index and systolic function to CFR and endothelial function in newly discovered, never treated hypertensive subjects without coronary heart disease and microvascular disease.
Methods

Study sample and protocol
The study sample comprised new discovered, never treated hypertensive subjects with recent history of known arterial hypertension (o5 years). Locally appointed ethic committee approved the study protocol. All participants underwent a standardized screening protocol to exclude secondary hypertension and coronary heart disease, including 24-h blood pressure (BP) monitoring, ECG stress test and nuclear medicine, echocardiographic and vascular carotid ultrasound exams: therefore, we excluded subjects with history of coronary artery disease or cerebrovascular disease, those with abnormal ECG, or abnormal ECG stress-test (cycle-ergometer, modified Bruce protocol, 25 W increment every 3 min up to physical exertion), or abnormal myocardial perfusion at single-photon emission computed tomography (SPECT) imaging, or with echocardiographic wall motion abnormalities. In all subjects, laboratory data were obtained in fasting conditions in the morning as part of clinical work-up for metabolic risk screening. Significant albuminuria (urinary excretion of albumin X30 mg/g of urinary creatinine) and diabetes (fasting glucose X126 mg/dl 19 ) were additional exclusion criteria. All participants who met inclusion criteria gave written informed consent to undergo the study protocol.
Echocardiography
A standard echocardiographic protocol was employed yielding elevated reproducibility for LV structure and function measurements. 20 All studies were performed using a General Electric VIVID 7 echocardiographic machine (GE Vingmed Ultrasound, Horten, Norway) with multifrequency matrix probes 1.5-4 MHz (model M3S) and taped on sVHS. Two-dimensionally guided M-Mode tracings were used, if correctly oriented, to measure LV structure, whereas linear measurements of LV structure were obtained in two-dimensional parasternal long-axis view in case of low echocardiographic window. 21 LV measurements were averaged from two to five cardiac cycles from views in which LV internal dimension was maximized in anatomically correct orientation following recommendation of the American Society of Echocardiography. 22 End-diastolic LV dimensions were used to calculate LV mass by a formula that yields values highly related (r ¼ 0.90) to necropsy LV weight. 23 All measurements were made by a single reader (VP), blind to subject's identification and clinical information.
LV systolic chamber function and myocardial contractility Ejection fraction (EF), LV midwall fraction shortening (MWS) and circumferential end-systolic stress were computed by standard methods. 2, 24 Myocardial afterload was assessed by computing the circumferential end-systolic stress, which can be measured using end-systolic American Society of Echocardiography LV measurement and simultaneous cuff BP in an invasively validated formula. 25 Since the majority of the myocardial fibres at mid-LV cavity are oriented circumferentially, LV shortening was assessed at midwall, 26 and related to MWS predicted for measured circumferential end-systolic stress level according to a standard method. 24 The ratio observed/predicted MWS (%) was termed stress-corrected MWS and used as indicator of myocardial contractility. 24 
Flow-mediated dilation
A standard protocol was used to assess endothelial function, as previously reported, 27 according to recommendations. 28 Briefly, between 09:00 and 10:00, postischaemic flow-mediated dilatation (FMD) of a brachial artery was evaluated with the patient in fasting condition and complete 24-h withdraw of caffeine or analogous, FANS and other medications, and of smoking. A cuff was placed at the nondominant upper-arm approximately 4 cm above the antecubital crease according to widely used method; [28] [29] [30] the brachial artery was imaged 1-4 cm above the antecubital fossa by a 11 MHz multifrequency linear probe (General Electric VIVID 7, Horten, Norway, probe 12L), to obtain the maximal arterial wall definition and arterial diameter (near-to-far wall-blood interfaces). A 4-min ischaemia was induced by inflating the cuff holding the sphygmomanometric pressure at 50 mmHg above the systolic BP measured before the test. After 4 min of ischaemia, the cuff was rapidly deflated and the brachial artery diameter was monitored for 4 min. Images were recorded on tape and, in addition, digital loops, of four cardiac cycles each, were stored at baseline and post-ischaemia at 30 s, 1 min, 2 min, 3 min and 4 min. The change of the arterial diameter during reactive hyperemia was calculated in relation to the baseline diameter obtained before the cuff occlusion, as following:
where t identifies the time after ischaemia. Since the arterial dilatation most-likely related to nitric oxide release occurs at 1 min after the ischaemia, we used FMD at 1 min postischaemia to represent the spontaneous endothelial function. 28, 29 In our laboratory, reproducibility of assessment of FMD was very good (single reader, between-reading difference FMD 0.372.7%, intraclass correlation coefficient 0.77). In a control group of 14 normotensive, normalweight, nondyslipidaemic, nondiabetic subjects with age 3879 (19-59) years, FMD was 1474% (2.5%ile of the distribution ¼ 8%). In addition, the spontaneous postischaemic FMD was compared to the capability of the brachial artery to dilate under infusion of nitroglycerin, a direct nitric oxide donor, assessing the endothelial-independent dilation (NMD). Accordingly, after approximately 15 min, the same brachial artery was reimaged (mean difference with baseline brachial artery preischaemia ¼ 0.00370.11 mm, intraclass correlation coefficient 0.99), and nitroglycerin (in a 0.9% NaCl solution at a concentration of 1 mg/ml) was infused by a pump at 1 mg/kg/min rate for 2 min. In our experience, no patient referred systemic effects during the test (warm skin, headache, flashing, increase in heart rate, decease in BP). In control subjects, the brachial artery is usually dilated to approximately 1675% (2.5%ile of the distribution ¼ 10%) at the 2nd minute of nitroglycerin infusion.
Coronary flow reserve
Sestamibi imaging
All patients underwent dipyridamole and rest cardiac imaging. Dipyridamole was infused intravenously at a dose of 0.74 mg/kg body weight given in a period of 6 min with monitoring of symptoms, BP and 12-lead electrocardiography. No patients developed severe angina, hypotension or other intolerable side effects. Tc-99m sestamibi, 555 MBq, was injected intravenously as a bolus 1-2 min before completion of the stress. Dynamic planar images were acquired for 60 s (4 frames/s) in the anterior view to measure the first transit counts in the pulmonary artery. SPECT imaging was performed 60 min later. Data were acquired using a rotating single head gamma camera (Elscint SP4HR, Elscint, Haifa, Israel) equipped with a low energy, allpurpose, parallel-hole collimator and connected with a dedicated computer system. In all, 32 projections (30 s/projection) were obtained over a semicircular 1801 arc, which extended from the 301 right anterior oblique to the left posterior oblique position. A 20% symmetric energy window centred on the 140 keV peak was used. Filtered backprojection was then performed with a low-resolution Butterworth filter with a cutoff frequency of 0.5 cycle per pixel, order 5.0. No attenuation or scatter correction was applied. Rest imaging was performed on a separate day following the same acquisition protocol. For first-pass analysis, 31 serial images of the first transit study were evaluated frame by frame for 3-5 s. A 3 Â 2 pixel square region of interest at main right pulmonary artery was assigned on the summed images. After smoothing, the area under the time-activity curve was calculated to obtain the time integral of the first-pass tracer counts for the pulmonary artery ( R [C(t)dt]). Global sestamibi activity was measured on two representative short-axis tomograms (at mid-basal and mid-apical levels). Estimated myocardial blood flow under stress and resting conditions was measured as myocardial counts/(
. Estimated CFR was expressed as the ratio stress/rest myocardial blood flow. 31 The accuracy and the reproducibility of this method have been previously assessed and were found good: a significant relationship between CFR estimated by sestamibi and CFR obtained by intracoronary Doppler was observed (r ¼ 0.85, Po0.001), with high intraclass correlation coefficients for intra-and interobserver reproducibility. 32 
Statistical analysis
Data in tables are mean7s.d., or absolute count, or percent. Parametric test were performed after logtransformation of the variables. Differences between subjects with vs those without LVH were tested using unpaired t-test for continuous variables, and using the w 2 analysis for proportions. Pearson's correlation was used to test bivariate correlations of LV geometry and systolic function variables with CFR, FMD and NMD. To test correlations of CFR and FMD with LV mass index and systolic function accounting for possible confounders, a series of separate multiple regression analyses were performed using age, gender, body mass index (BMI), systolic BP and total/HDL cholesterol as standard set of covariates, and LV mass index, EF and stresscorrected MWS alternatively; the standardized correlation coefficients (betas) were reported in Table 3 . Furthermore, the unstandardized residuals of the multiple linear regression analyses of CFR vs age, gender, BMI, systolic BP, total/HDL cholesterol, as well as the multiple linear regression analyses of FMD vs age, gender, BMI, systolic BP, total/HDL cholesterol; the residuals were individually plotted against LV mass index (Figure 3) , and the Pearson's correlation was used to test whether the residuals were significantly related with LV mass index. In all cases, Po0.05 was used to indicate the statistical significance.
Results
General characteristics of the study population
The 21 hypertensive subjects enrolled in the study were mostly in the middle age and were, on average, mildly overweight (Table 1) ; five hypertensives had LVH. For descriptive purpose hypertensives with LV were compared to those without LVH, and no statistically significant differences emerged in terms of mean age, BMI, clinical BP, metabolic profile, relative wall thickness, EF and stress-corrected MWS (all P40.1, data not shown), with the exception of a higher prevalence of men among patients without LVH (15/16 vs 2/5, Po0.05), potentially due to higher BMI in women than men (29 vs 26 kg/m 2 , Po0.01) and use of indexation of LV mass by height 2.7 to reveal obesity-related LVH. Basal brachial artery diameter was similar between the two groups (P ¼ 0.8, data not shown), as it was the brachial diameter indexed by body height (2.5 cm/m in LVH vs 2.6 cm/m in normal LV mass group). At baseline and after dipyridamole infusion, patients with LVH and those without had similar myocardial metabolic demand by systolic BP-heart rate product (data not shown, all P40.6). In univariate analysis, CFR, FMD and NMD did not differ significantly between patients with vs those without LVH (Figures 1 and 2 ). Significantly abnormal FMD (o8%) was found in approximately 47% of our study sample, with no significant difference between hypertensive with vs those without LVH (40 vs 50%, P ¼ NS).
Correlations of CFR and FMD with LV mass index and systolic function
The correlation coefficients of CFR with FMD (r ¼ 0.32) and with NMD (r ¼ 0.48) were mild-tomoderate and did not reach the statistically significance (both 0.05oPo0.1). In bivariate analysis, LV mass index showed no significant correlation with CFR (r ¼ À0.08, P ¼ NS), and showed only a mild negative correlation with FMD (r ¼ À0.33) and with NMD (r ¼ À0.23) without reaching the statistical significance (both P40.09). Similarly, EF and stress-corrected MWS showed only mild and not significant correlations with CFR (r ¼ 0.33 and r ¼ 0.17, respectively), FMD (r ¼ 0.14 and 0.09, respectively) and NMD (r ¼ 0.16 and 0.27, respectively) (all P ¼ NS). CFR showed a mild trend toward a negative correlation with the delta per cent increment of the systolic BP-heart rate product at peak dipyridamole infusion without reaching the statistical significance (r ¼ À0.24, P ¼ NS). Owing to potential confounding effects of covariates, multivariate analyses were performed.
Multivariate analyses of the relation of LV geometry and systolic function to CFR and endothelial function After accounting for age, gender, BMI, total/HDL cholesterol and systolic BP (confounders, Table 2), LV mass index and EF remained not significantly correlated with CFR. As shown in Figure 3 , panel a, LV mass index did not correlate with unstandardized residuals of the regression of CFR vs confounders (age, gender, BMI, systolic BP and total/ HDL cholesterol). In contrast, stress-corrected MWS was positively and significantly related with CFR independent of covariates (Table 3) ; in fact, the residuals of the CFR vs confounders were significantly related with the stress-corrected MWS, as shown in Figure 3 , panel b. Moreover, LV mass index showed a confounder-adjusted negative correlation with FMD; in fact, the unstandardized residuals of the regression of FMD vs confounder (age, gender, BMI, systolic BP and total/HDL cholesterol) showed a significant correlation with LV mass index (Figure 3c ). EF and stress-corrected MWS showed no significant covariate-adjusted correlation with FMD. No significant correlation was found between the stress-corrected MWS and the unstandardized residuals of FMD vs confounders (Figure 3d) . To explore the extent to which endothelial function of the brachial artery affected the correlation of LV mass index with CFR, we performed an additional multiple regression analyses, in which LV mass showed no significant independent correlation with CFR (b ¼ À0.08, P ¼ NS).
In another alternative set of multiple regression analyses, NMD was used for FMD in the set of covariates including age, gender BMI, total/HDL cholesterol, and we found that the adjusted standardized correlation coefficient of LV mass index to CFR improved (b ¼ À0.37), albeit it remained not statistically significant.
Discussion
Potential associations of LVH and myocardial systolic dysfunction with impaired CFR and endothelial dysfunction preceding haemodynamically significant coronary artery disease may be relevant to understand the associations of LVH and systolic dysfunction with atherosclerosis and cardiovascular outcome. 1, 33, 34 A number of confounding factors may impact on the correlations of LVH and myocardial dysfunction with CFR and endothelial dysfunction; in particular, subclinical coronary artery disease, which is likely to be associated with LVH especially in long-standing hypertension. 3 Therefore, to explore the associations of LV mass index and myocardial systolic function with CFR and FMD in hypertensive subjects minimizing the impact of confounding factors, we selected a group of patients with newly discovered uncomplicated arterial hypertension, never treated, with normal ECG stress test, and without microalbuminuria. In spite of the stringent selection criteria, five of 21 hypertensive patients recruited (24%) had LVH defined by LV mass/height.
2.7
Our findings showed that lower CFR was significantly and independently associated with lower resting stress-corrected MWS, a measure of myocardial contractility. Previously, it was reported an association of lower MWS with lower resting myocardial blood flow assessed by SPECT, 35 but CFR was not tested. Lower myocardial contractility may be associated with lower coronary blood flow; however, the association of lower resting myocardial contractility to lower CFR by dipyridamole stress testing is new. Since impaired myocardial contractility is associated with higher myocardial fibrosis, and structural remodelling of the intramyocardial coronary arterioles and the accumulation of fibrillar collagen are decisive factors for a reduced coronary dilatory capacity, 36 our findings may suggest that impaired myocardial contractility may characterize a cardiac phenotype associated with initial impairment of CFR already in the early stage of uncomplicated arterial hypertension, and independent to coronary artery stenosis.
To extend our observation to potential pathophysiologic mechanisms underlying associations of LV structural and functional abnormalities with CFR in hypertensive patients, we contextually explored correlation of LV mass index and systolic function with endothelial function of a brachial artery. In fact, there is at least one evidence of an association between peripheral endothelial dysfunction with coronary endothelial dysfunction assessed invasively. 5 This is relevant because LVH is associated with cardiovascular risk factors and atherosclerosis even in asymptomatic patients. 33 Cardiovascular risk factors are in turn associated with endothelial dysfunction, 4 which is in turn implicated in the pathogenesis of atherosclerosis 37 and cardiovascular events. 38 In our bivariate analysis, higher LV mass index showed a trend toward of an association with lower FMD. This finding is in agreement with previous reports in middle-age hypertensive subjects. 39, 40 However, in the multivariate analysis adjusting for a number of relevant confounding factors, LV mass index emerged as a significant independent correlate of the FMD, with a moderately strong adjusted standardized correlation coefficient. This was expected based on finding reported by Perticone et al, 41 who described lower forearm blood flow increase by acetycholine in patients with LVH vs those with normal LV mass. In addition, however, we showed that LV chamber and midwall systolic function were not significant correlates of FMD, which was not previously reported.
The independent relation of LVH with impaired CFR is disputed (Table 3 ). Initial works have described typical stress-induced angina pectoris in subjects without significant epicardial coronary lesions or LV dysfunction. 6 Strauer and colleagues 7 described reduced CFR in hypertensive subjects with angina pectoris and LVH with no angiographically significant epicardial coronary lesions. However, Strauer also reported normal CFR with haemodynamically compensated LVH. 12 In a work from Opherk et al 10 in subjects with arterial hypertension and without obstructive coronary lesions on angiogram, ECG-defined LVH was found to be associated with markedly reduced CFR measured by argon method without significant alteration of myocardial microvasculature in myocardial specimens showing insignificant interstitial fibrosis. Opherk et al 10 emphasized the role of coronary resistance and LV end-diastolic pressure as determinants of the reduced CFR associated with LVH. More recently, increased coronary resistance and impaired CFR has been reported in hypertensive subjects with LVH vs those without, using trans-oesophageal echocardiography and adenosine infusion. 42 Reduced coronary flow velocity reserve has been reported in hypertensives with vs those without echocardiographic LVH using trans-thoracic echocardiography, 43 a technique that allows evaluation of intracoronary peak velocities but not coronary dimension change and therefore cannot be use to extrapolate changes in myocardial blood flow. Although evidences have been accumulated on the fact that CFR is impaired in many types of pathologic hypertrophy, the anatomic or biochemical basis for these observations remained elusive. 44 Impaired CFR was reported in hypertensive subjects without clear-cut LVH. 13 Vogt et al 11 found no significant relation between LV mass index and CFR assessed invasively. Similar results were reported by Houghton et al 14 using intracoronary Doppler method to measure CFR. Houghton et al 14 also found that hypertensive subjects with perfusion defect at tallium-201 scan had lower CFR and also showed higher LV mass index, reinforcing the confounding effect of coronary artery disease or microangiopathy. Indeed, the association of LVH with silent coronary heart disease has been reported in hypertensive subjects with moderately severe arterial hypertension and ECG-LVH in the LIFE study; 18 interestingly, in a subgroup of LIFE patients with ECG-LVH, echocardiographic LVH was associated with lower CFR by positron emission tomography and lower FMD. 45 Our patients did not show ECG signs of LVH, were significantly younger (47710 vs 6476, Po0.05), received higher dose of dipyridamole (0.76 vs 0.56 mg/kg or lower in other studies). Others found weak and clinically not relevant relationship between LV mass index and CFR. 15, 17 Motz et al 46 first reported coronary endothelial dysfunction in hypertensive undergoing coronary angiography for angina pectoris. In our study, FMD findings did not impact on the lack of relation between LV mass index and CFR. However, as in current practice, in our study, CFR was evaluated by dipyridamole infusion, therefore using a not endothelium-dependent stimulus to increase myocardial blood flow. It has been reported that in the early stage of hypertension, atherosclerotic risk factors mostly impair endothelium-dependent coronary vasodilatation. 47 Therefore, we may speculate that in the early stage of arterial hypertension, use of dipyridamole to evaluate a nonhaemodynamically limited CFR may mask potentially endothelium-dependent mechanisms of coronary dysfunction. Interestingly, in our study the relation of LV mass index with NMD was not statistically and physiologically relevant.
Study limitations
Owing to our study sample size, our statistical tests may be underpowered. In fact, we found a difference of 0.2 in CFR between LVH and normal LV mass groups; with such a between-group difference, to reach at least 80% statistical power (giving 0.5 as common s.d.) with an a error set at 5% (two-tailed) and with the ratio between the group-size of 0.313, a total sample size of 289 hypertensive subjects would have been needed. Notwithstanding, we expected a greater between-group difference (between 0.5 and 0.8), and in the best scenario, our sample size would have allowed to detect a between-group difference in CFR of 0.8 with a statistical power 480% at an a error set at 5% (two-tailed); to reach such a difference, giving the mean CFR in the group with LVH of 1.6, the mean CFR in those without LVH was expected to be approximately of 2.4 instead of 1.8, as we found. Therefore, being the between-group difference so small and not clinically relevant, we considered unethical to continue patients recruitment. Moreover, our study did not include CRF in a matched control group of normotensive, normalweight, nondiabetic subjects, which might be considered a limitation of the present study. However, it is well established that hypertensive subjects have lower CFR than normotensive subjects independent to LVH; 16 therefore, performing dipyridamole-stress SPECT testing to replicate findings well established in literature was considered unethical. In fact, the matter of the current research is to establish whether LVH is associated with impaired CFR in hypertensive subjects independent to coronary artery stenosis and traditional proatherosclerotic risk factors.
The reproducibility of assessment of LV mass by echocardiographic procedures was good and was previously reported, 20 as it was the reproducibility and reliability of assessment of CFR by SPECT procedure. 32 Another potential limitation of the study is the fact that none of the patients included showed concentric LV geometry.
While covariate-adjusted standardized coefficients of correlation of LV mass index with FMD and of stress-corrected MWS with CFR were statistically significant, precision of prediction may be suboptimal; therefore our data are indicative of significant associations between groups of subjects and should not be used for inferences in single patients.
Conclusions
Our data in clinically healthy, new discovered hypertensive subjects, never treated and mostly in the middle age, suggest that in the early stage of arterial hypertension, LVH can be associated with endothelial dysfunction while maximal dipyridamole-dependent CFR may be preserved; nevertheless, in the early stage of arterial hypertension, a cardiac phenotype presenting with lower myocar-dial contractility, assessed by stress-corrected MWS, was associated with lower CFR independent to LVH.
